Tumour necrosis factor inhibitor therapy and infection risk in axial spondyloarthritis: results from a longitudinal observational cohort

被引:31
作者
Wallis, Dinny [1 ]
Thavaneswaran, Arane [1 ]
Haroon, Nigil [1 ]
Ayearst, Renise [1 ]
Inman, Robert D. [1 ]
机构
[1] Univ Toronto, Toronto Western Hosp, Div Rheumatol, Toronto, ON M5S 1A1, Canada
关键词
axial spondyloarthritis; ankylosing spondylitis; infection; biologic; SOCIETY CLASSIFICATION CRITERIA; FACTOR-ALPHA ANTAGONISTS; RHEUMATOID-ARTHRITIS; ANKYLOSING-SPONDYLITIS; SERIOUS INFECTIONS; HOSPITALIZATION; METHOTREXATE; TRIALS;
D O I
10.1093/rheumatology/keu255
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Methods. Data were extracted from a longitudinal observational cohort of patients with axSpA. Infection rates were calculated and multivariate analysis was performed to investigate the association of independent variables with infection. Results. Data were analysed for 440 patients followed for a total of 1712 patient-years (pys). A total of 259 infections, of which 23 were serious, were recorded in 185 patients. The overall rate of any infection was 15 (95% CI 13, 17)/100 pys and the serious infection rate was 1.3 (95% CI 0.9, 2.0)/100 pys. There was no significant difference in the rate of any infection or serious infection in patients on TNFis compared with patients never on biologic agents. In the multivariate analysis, DMARD treatment, but not TNFi treatment, was associated with risk of infection. Age, disease duration, smoking status, BASFI, BASDAI, co-morbidity score and hospitalization were not associated with an increased risk of infection. Conclusion. The serious infection rate in axSpA in this observational cohort is low when compared with rates reported in other rheumatic diseases. Biologic use was not a significant risk factor for serious infection.
引用
收藏
页码:152 / 156
页数:5
相关论文
共 13 条
[1]   Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists [J].
Askling, Johan ;
Fored, C. Michael ;
Brandt, Lena ;
Baecklund, Eva ;
Bertilsson, Lennart ;
Feltelius, Nils ;
Coster, Lars ;
Geborek, Pierre ;
Jacobsson, Lennart T. ;
Lindblad, Staffan ;
Lysholm, Jorgen ;
Rantapaa-Dahlqvist, Solbritt ;
Saxne, Tore ;
van Vollenhoven, Ronald F. ;
Klareskog, Lars .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (10) :1339-1344
[2]   Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease [J].
Burmester, Gerd R. ;
Panaccione, Remo ;
Gordon, Kenneth B. ;
McIlraith, Melissa J. ;
Lacerda, Ana P. M. .
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (04) :517-524
[3]   Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor α antagonists [J].
Curtis, Jeffrey R. ;
Patkar, Nivedita ;
Xie, Aiyuan ;
Martin, Carolyn ;
Allison, Jeroan J. ;
Saag, Michael ;
Shatin, Deborah ;
Saag, Kenneth G. .
ARTHRITIS AND RHEUMATISM, 2007, 56 (04) :1125-1133
[4]   The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case-control study [J].
Dixon, W. G. ;
Kezouh, A. ;
Bernatsky, S. ;
Suissa, S. .
ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (06) :956-960
[5]   Predictors of infection in rheumatoid arthritis [J].
Doran, MF ;
Crowson, CS ;
Pond, GR ;
O'Fallon, WM ;
Gabriel, SE .
ARTHRITIS AND RHEUMATISM, 2002, 46 (09) :2294-2300
[6]   Frequency of infection in patients with rheumatoid arthritis compared with controls - A population-based study [J].
Doran, MF ;
Crowson, CS ;
Pond, GR ;
O'Fallon, WM ;
Gabriel, SE .
ARTHRITIS AND RHEUMATISM, 2002, 46 (09) :2287-2293
[7]   Serious infections in patients with ankylosing spondylitis with and without TNF blockers: a systematic review and meta-analysis of randomised placebo-controlled trials [J].
Fouque-Aubert, Anne ;
Jette-Paulin, Laetitia ;
Combescure, Christophe ;
Basch, Andre ;
Tebib, Jacques ;
Gossec, Laure .
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (10) :1756-1761
[8]   Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly [J].
Galloway, James B. ;
Hyrich, Kimme L. ;
Mercer, Louise K. ;
Dixon, William G. ;
Fu, Bo ;
Ustianowski, Andrew P. ;
Watson, Kath D. ;
Lunt, Mark ;
Symmons, Deborah P. M. .
RHEUMATOLOGY, 2011, 50 (01) :124-131
[9]   Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry [J].
Greenberg, J. D. ;
Reed, G. ;
Kremer, J. M. ;
Tindall, E. ;
Kavanaugh, A. ;
Zheng, C. ;
Bishai, W. ;
Hochberg, M. C. .
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (02) :380-386
[10]   Initiation of Tumor Necrosis Factor-α Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune Diseases [J].
Grijalva, Carlos G. ;
Chen, Lang ;
Delzell, Elizabeth ;
Baddley, John W. ;
Beukelman, Timothy ;
Winthrop, Kevin L. ;
Griffin, Marie R. ;
Herrinton, Lisa J. ;
Liu, Liyan ;
Ouellet-Hellstrom, Rita ;
Patkar, Nivedita M. ;
Solomon, Daniel H. ;
Lewis, James D. ;
Xie, Fenglong ;
Saag, Kenneth G. ;
Curtis, Jeffrey R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (21) :2331-2339